Quantitative Analysis of Tyrosine Hydroxylase mRNA for Sensitive Detection of Neuroblastoma Cells in Blood and Bone Marrow | Zendy

Catarina Träger | Zendy; Per Kogner | Zendy; Magnus Lindskog | Zendy; Frida Ponthan | Zendy; Anita Kullman | Zendy; Bertil Kågedal | Zendy

Open Access

Quantitative Analysis of Tyrosine Hydroxylase mRNA for Sensitive Detection of Neuroblastoma Cells in Blood and Bone Marrow

Author(s) -

Catarina Träger,

Per Kogner,

Magnus Lindskog,

Frida Ponthan,

Anita Kullman,

Bertil Kågedal

Publication year - 2003

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/49.1.104

Subject(s) - neuroblastoma , tyrosine hydroxylase , bone marrow , minimal residual disease , messenger rna , medicine , tyrosine , pathology , endocrinology , biology , immunohistochemistry , gene , biochemistry , cell culture , genetics

Sensitive monitoring of minimal residual disease may improve the treatment of neuroblastoma in children. To detect and monitor neuroblastoma cells in blood and bone marrow, we developed a quantitative method for the analysis of tyrosine hydroxylase mRNA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research